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A B S T R A C T
When biomaterials are implanted in the human body, the surfaces of the implants become favorable sites for
microbial adhesion and biofilm formation, causing peri-implant infection which frequently results in the failure
of prosthetics and revision surgery. Ti–Mo alloy is one of the commonly used implant materials for load-bearing
bone replacement, and the prevention of infection of Ti–Mo implants is therefore crucial. In this study, bacterial
inhibitory copper (Cu) was added to Ti–Mo matrix to develop a novel Ti–Mo–Cu alloy with bacterial inhibitory
property. The effects of Cu content on microstructure, tensile properties, cytocompatibility, and bacterial in-
hibitory ability of Ti–Mo–Cu alloy were systematically investigated. Results revealed that Ti–10Mo–1Cu alloy
consisted of α and β phases, while there were a few Ti2Cu intermetallic compounds existed for Ti–10Mo–3Cu and
Ti–10Mo–5Cu alloys, in addition to α and β phases. The tensile strength of Ti–10Mo-xCu alloy increased with Cu
content while elongation decreased. Ti–10Mo–3Cu alloy exhibited an optimal tensile strength of 1098.1 MPa
and elongation of 5.2%. Cytocompatibility study indicated that none of the Ti–10Mo-xCu alloys had a negative
effect on MC3T3-E1 cell proliferation. Bacterial inhibitory rates against S. aureus and E. coli increased with the
increase in Cu content of Ti–10Mo-xCu alloy, within the ranges of 20–60% and 15–50%, respectively. Taken
together, this study suggests that Ti–10Mo–3Cu alloy with high strength, acceptable elongation, excellent cy-
tocompatibility, and the bacterial inhibitory property is a promising candidate for biomedical implant appli-
cations.
1. Introduction
Titanium (Ti) and its alloys have received increasing attention in the
field of orthopedics and dentistry, due to their excellent mechanical
properties, corrosion resistance and biocompatibility [1–3]. However,
the most widely used Ti and its alloys, e.g. commercial pure Ti (CP–Ti)
and Ti–6Al–4V alloy (Ti64) (hereafter the composition of all alloys are
given by wt.%), have some potential problems, including releasing
toxic Aluminum (Al) or Vanadium (V) ions, stress-shielding because of
the mismatch of elastic modulus between implant and bone, and
bacterial infection [4,5]. Hence, many new β-type Ti alloys such as
Ti–Nb–Zr and Ti–Mo based alloys have been designed and developed to
enhance the biocompatibility and reduce the stress-shielding effect
[6–9]. Among them, Ti–Mo based alloys with 4–20% Mo have attracted
considerable attention due to their relatively low cost, high strength,
low elastic modulus and excellent biocompatibility [10–15]. From the
viewpoint of alloy design, less Mo is always preferred in the Ti–Mo
alloys system because (1) Mo is expensive, minimizing the use of Mo
reduces the cost; (2) Mo has a high melt pointing (2620 °C) than Ti
(1660 °C), minimizing the use of Mo makes the Ti–Mo alloys easier to
https://doi.org/10.1016/j.bioactmat.2020.04.012
Received 25 March 2020; Received in revised form 15 April 2020; Accepted 16 April 2020
Peer review under responsibility of KeAi Communications Co., Ltd.
∗ Corresponding author.
∗∗ Corresponding author.
E-mail addresses: ylei@hebut.edu.cn (L. Yang), luxin@ustb.edu.cn (X. Lu).
1 These authors contributed equally.
Bioactive Materials 5 (2020) 659–666
2452-199X/ © 2020 Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. This is an open access article under the CC BY-NC-ND 
license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).
T
be processed. In addition, based on previous studies [16], 10% Mo is
required in Ti–Mo alloys to retain the β-phase to make the alloy with a
low elastic modulus. Therefore, the composition of Ti–10Mo is selected
in this study.
On the other hand, bacterial infection is another major cause of Ti
implants failure. It has been reported that even if surgery is operated
under strict aseptic conditions, the average infection rate of orthopedic
Ti implants is still as high as 0.5%–5% [17,18]. Therefore, developing
Ti alloys with bacterial inhibitory properties is in urgent need. To date,
there are mainly two approaches to enhance the bacterial inhibitory
properties of Ti implants. One is the surface modification, e.g. ion im-
plantation [19] and plasma immersion ion implantation (PIII) [20]. The
other is to add bacterial inhibitory elements to Ti matrix, such as copper
(Cu), silver (Ag), and zinc (Zn) [21–23]. Compared with surface mod-
ification, adding the bacterial inhibitory elements to the alloy matrix
has many distinctive advantages, such as higher wear resistance and
long-term bacterial inhibitory properties. Among bacterial inhibitory
elements mentioned above, Cu has a low cost and cytotoxicity, and high
antimicrobial efficiency. In addition, Cu is an essential element of
several enzymes and a metabolizable agent [24], and is able to enhance
vascularization and promote osteogenic differentiation and bone
healing [25,26]. It was reported that some bacterial inhibitory metals
have been successfully developed by adding Cu element into stainless
steel, Ti and other metal alloys [27–30]. However, the effects of Cu on
the comprehensive properties of Ti–Mo alloy are still scarce in the lit-
erature.
In the present study, Cu is added to Ti–10Mo alloy to develop novel
β-type Ti alloys with low elastic modulus and bacterial inhibitory
property. Given that the excessive Cu intake may result in cytotoxicity,
1–5 wt% Cu was added. The microstructure, tensile properties, cyto-
compatibility and bacterial inhibitory properties of Ti–10Mo-xCu alloy
were investigated. The aims of this study were to systematically eval-
uate the newly developed Ti–10Mo-xCu alloy to support their potential
applications in medical implants.
2. Materials and methods
2.1. Materials preparation
Commercially available Ti, Mo, and Cu powders (99.9% purity, Tian
Tai Long Metal Materials Co., Ltd, China, and Beijing Xin Rong Yuan
Co., Ltd, China) were used as raw materials. The chemical compositions
of the powders are listed in Table 1. In order to decrease the oxygen
content and hence enhance the mechanical properties, Ti powders were
first coated by polyethylene glycol (PEG, Aladdin Shanghai Aladdin
Bio-Chem Technology Co., Ltd, China). The amount of PEG was 1 wt%
and the coating process is schematically shown in Fig. 1. The coated Ti,
Mo and Cu powder with a nominal composition of Ti–10Mo-xCu
(x = 0,1,3,5) were mixed in a blender for 6 h. Subsequently, the mixed
powders were poured into a silicone mold and compacted by cold
isostatic pressing (CIP) at 200 MPa. Finally, the green compacts were
sintered at different temperatures in the range of 1300–1420 °C in a
tube furnace under an argon atmosphere. The PEG, which boiling point
was about 250 °C, was decomposed and volatilized completely during
sintering. The O content of Ti, Mo, and Cu powders was below 0.15 wt
%, and the particle size of all powders was ≤45 μm. The detailed
information of impurity contents and particle size of the powders were
described elsewhere [31,32].
2.2. Microstructure characterization
The Archimedes method was used to measure the density of sintered
Table 1
Chemical composition of Ti, Mo and Cu powders.
Powder Chemical composition (wt.%)
H C N O Si Cl Fe Cu Ti Mo
Ti 0.03 0.02 0.04 0.15 0.02 0.05 0.02 0 Bal. 0
Mo 0.07 0.05 0.05 0.20 0.02 0.01 0.02 0 0 Bal.
Cu 0.03 – – 0.02 – 0.04 0.01 Bal. 0 0
Fig. 1. Schematic illustration of the coating process of Ti powder with PEG.
Fig. 2. Influence of sintering temperature and Cu contents on the relative
density of Ti–10Mo-xCu alloy.
Fig. 3. XRD patterns of Ti–10Mo-xCu alloy with different Cu contents.
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specimens based on the ASTM B962-14 (2017) standard [33]. The
phase constituent and microstructure of the specimens were char-
acterized using an X-ray diffractometer (Rigaku, Japan), scanning
electron microscope (SEM, JSM-6480LV, Japan), and transmission
electron microscopy (TEM, Tecnai G2 F20, USA). The target of the X-
ray diffractometer was Copper (Cu) while the wavelength was
0.15406 nm. The voltage and electric current for X-ray diffractometer
are 40 kV and 50 mA, respectively. The scanning speed is 10°/min, and
the scanning angle is in the range of 20°–90°. Before the microstructural
analysis using SEM, all specimens were ground with SiC abrasive paper
to 2000#, polished, and then etched using Kroll's etchant. The Kroll's
etchant consists of hydrofluoric acid, nitric acid, and distilled water,
and the volume ratio is 5:10:85. The TEM specimens were prepared
using a focused ion beam (FIB, Helios nanolab600i, USA).
2.3. Mechanical testing
The tensile property of Ti–10Mo-xCu alloy was tested by an
INSTRON 4206 machine under a strain rate of 0.002 s−1. The diameter
and gauge length of specimens were 3 mm and 15 mm, respectively.
The tensile strength and elastic modulus were calculated from the
engineering stress-strain curves, and the fractured surface was observed
by SEM.
2.4. Cytocompatibility testing
Murine osteoblast cells (MC3T3-E1) obtained from cell bank from
the Chinese academy of sciences was adopted to evaluate the cyto-
compatibility of Ti–10Mo-xCu alloy. MC3T3-E1 cells were seeded in 24-
well plates containing sterilized Ti–10Mo-xCu alloy, and initial density
was 1 × 105 cells/well. Then the plates were cultured at 37 °C with 5%
CO2. At day 1 and day 3, the culture medium was discarded and 20 μL
Cell Counting Kit-8 (CCK-8, Sigma) solution was added into each well,
and cultured for another 4 h. Finally, the absorbance of each well was
measured on a Bio-Rad microplate reader at 570 nm. The cell relative
growth rate (CRGR) was calculated based on the following formula:
= ×CRGR OD OD( specimen/ blank) 100%nm nm570 570 (1)
where OD570nm specimens and OD570nm blank are the optical density of
the Ti-10-xCu specimens and blank controls, respectively. Based on the
International Standard ISO 10993–5 [34], the cytotoxic level was ca-
tegorized into six groups: 0 ≥ 100%; Ⅰ: 75%–99%; Ⅱ: 50%–74%; Ⅲ: 25
Fig. 4. Microstructure of Ti–10Mo-xCu alloy with different Cu contents: (a) Ti–10Mo; (b) Ti–10Mo–1Cu; (c) Ti–10Mo–3Cu; (d) Ti–10Mo–5Cu; (e) Morphology of
Ti2Cu phase in Ti–10Mo–5Cu alloy; (f) Corresponding selected area diffraction pattern of the area Z1 in (e).
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%-49%; Ⅳ: 1%–24%; Ⅴ: ≤1%. In addition, the live and dead cells were
stained by a LIVE/DEAD kit (Thermo Fisher Scientific) at days 1 and 3.
The procedure was as follows: (1) the medium was removed; (2) 4 μM
calcein‐AM and 2 μM ethidium homodimer‐1 in phosphate-buffered
saline (PBS) solution was added; (3) the plate was incubated in the dark
for 15 min at 37 °C; (4) the cells were observed by a confocal laser
scanning microscope (Zeiss 880, Germany).
2.5. Bacterial inhibitory test
In order to evaluate the bacterial inhibitory properties of Ti–10Mo-
xCu alloy, Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli)
strains were cultured with the alloys. Before culturing, all specimens
were sterilized with UV irradiation for 1 h. The diameter and thickness
of the specimens were 8 mm and 0.5 mm, respectively. Ti–10Mo alloy
was used as a control. Before experiments, the S. aureus and E. coli were
cultured in an NB (nutrient broth) at 37 °C to a concentration of
106 CFU/mL. Then it was diluted to a concentration of 105 CFU/mL by
PBS solution. 50 μL diluted bacteria suspension was added to the 24-
well plate to co-culture with the specimens for 24 h at 37 °C. After 24 h
culturing, the plate-count method was used to calculate the number of
bacterial based on the GB/T 2591 standard [35]. The bacterial in-
hibitory rate (R) was calculated based on the following formula:
R = (Nreference − Nspecimen) / Nreference × 100% (2)
Where Nreference and Nspecimen are the numbers of the bacterial colonies
on Ti–10Mo and Ti-10-xCu specimens, respectively.
2.6. Cu ion release
Ti–10Mo-xCu alloys were immersed in the deionized water at a ratio
of 3 cm2/ml (the surface area of the disc to the volume of media) to
examine the Cu ion release. After day 1, 3, 5, and 7, ICP-MS (in-
ductively coupled plasma mass spectrometry, PerkinElmer, Optima
5300 DV) method was used to evaluate the Cu ion concentration. Five
tests were repeated at each time, and the average value was reported.
2.7. Statistical analysis
All the tests were performed in triplicate. Results of mechanical,
cytocompatibility, bacterial inhibitory, and Cu ion release tests are
expressed as means ± standard deviations. The differences between
groups were observed by one-way analysis of variance (SPSS 14.0 for
Windows, SPSS Inc., Chicago, IL) to determine the statistical sig-
nificance. P < 0.05 was considered statistically significant.
3. Results and discussion
3.1. Density and microstructure
Fig. 2 shows the variation in the relative density of specimens as a
function of sintering temperature and Cu contents. The relative density
strongly depends on the sintering temperature and Cu contents. Gen-
erally, the relative density increases gradually and then tends to sta-
bilize at a certain level (about 98%) with the increasing sintering
temperature at the same Cu content. In addition, the relative density
increases with Cu content at the same sintering temperature, and the
minimum sintering densification temperature decreases gradually with
Cu content. This is mainly because Cu (melting point 1083.4 °C) is a
low-melting metal compared with Ti (melting point 1660.0 °C) and Mo
(melting point 2620 °C). Thus, with increasing Cu content, the melting
pointing of the alloys decreases and the corresponding minimum sin-
tering densification temperature also decreases. For the Ti–10Mo–1Cu,
Ti–10Mo–3Cu, Ti–10Mo–5Cu alloys, the minimum sintering densifica-
tion temperature is 1400 °C, 1380 °C, and 1360 °C, respectively, and the
relative density is in the range of 98.12%–98.35%.
Fig. 3 shows the XRD patterns of Ti–10Mo-xCu alloy with different
Cu contents. It can be seen that all the Ti–10Mo-xCu alloy mainly
consists of α and β phases. For the Ti–10Mo–3Cu and Ti–10Mo–5Cu
alloy, there is also a small amount of Ti2Cu phase, which increases with
the Cu content increase. This result agrees with the previous results
reported by Campo [36].
The SEM images of Ti–10Mo-xCu alloy and TEM images with the
Fig. 5. Tensile stress-strain curves of Ti–10Mo-xCu alloy with different Cu
contents.
Table 2
Tensile properties of Ti–10Mo-xCu alloy with different Cu contents and common Cu-bearing Ti alloys.
Materials Preparation UTS/MPa El./% E/GPa
Ti–10Mo PM 916.2 ± 11.2 14.8 ± 0.3 77.6 ± 1.3 This study
Ti–10Mo–1Cu PM 1002.3 ± 12.2 8.2 ± 0.1 73.5 ± 1.6 This study
Ti–10Mo–3Cu PM 1098.1 ± 9.4 5.2 ± 0.2 71.1 ± 0.9 This study
Ti–10Mo–5Cu PM 1162.2 ± 13.6 1.97 ± 0.2 74.9 ± 1.5 This study
CP-Ti Casting 375.1 ± 5.4 14.1 ± 0.4 106.1 ± 2.1 This study
Ti–6Al–4V Casting 788.1 ± 9.1 2.53 ± 0.1 110.2 ± 1.8 This study
Ti–5Cu Casting 535 14.5 – [37]
Ti–6Al–4V–1Cu Casting 1016 2.8 99 [38]
Ti–6Al–4V–4Cu Casting 884 1.0 88 [38]
Ti–6Al–4V–10Cu Casting 387 0.2 162 [38]
Ti–3Cu Annealing (740 °C) 575 21 – [39]
Ti–5Cu Annealing (740 °C) 594 26 – [39]
Ti–7Cu Annealing (740 °C) 649 23 – [39]
Ti–3Cu Annealing (830 °C) 584 24 – [39]
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corresponding selected area diffraction patterns of Ti–10Mo–5Cu alloys
are shown in Fig. 4. As Fig. 4 (a)–(d) show, Ti–10Mo-xCu alloy with
high relative density can be obtained by the PM method, which is
consistent with the densification result (Fig. 2). All specimens exhibit a
uniform Widmanstätten structure, which consists of α and β phases.
Though the Ti2Cu phase exists in XRD for Ti–10Mo–3Cu and Ti–10-
Mo–5Cu alloys, it is not observed in SEM. This may be because the size
of Ti2Cu is too small to be distinguished. To confirm the existence of the
Ti2Cu phase, the microstructure of Ti–10Mo–5Cu alloy is characterized
using TEM, as shown in Fig. 4(e). It can be seen that there were some
dark particles (marked as Z1) in the size range of 80–150 nm. The EDS
analysis revealed that the area Z1 consisted of Ti and Cu with an atomic
percentage of 68.72 and 31.28. The corresponding selected area dif-
fraction pattern of the area Z1 is shown in Fig. 4(f). The EDS results
together with the corresponding selected area diffraction pattern con-
firmed that the dark particle is the Ti2Cu phase.
3.2. Mechanical properties
The typical engineering stress-strain curves of Ti–10Mo-xCu alloy
with different Cu content, together with as-cast CP-Ti and Ti64 alloys as
controls, are presented in Fig. 5. It can be seen that the tensile strength
of Ti–10Mo-xCu alloy increases with the rise in the Cu content while the
elongation decreases gradually. All Ti–10Mo-xCu alloy exhibit higher
tensile strength than as-cast CP Ti and Ti64 alloys.
The mechanical properties of the PM-fabricated Ti–10Mo-xCu alloy
with different Cu content are summarized in Table 2, and compared
with common Cu-bearing Ti alloys, including Ti–Cu and Ti–6Al–4V–Cu
alloys. It can be seen that the tensile strength of Ti–10Mo-xCu alloy is in
the range of 916.2–1162.2 MPa while the elongation decreases from
14.8 to 1.97. This is mainly because of the existence of the Ti2Cu phase
and solid solution strengthening of Cu. With a higher Cu content, the
solid solution strengthening effect is gradually enhanced, which leads
to increased strength. In addition, it is well known that Ti2Cu is an
intermetallic, which is a hard-brittle phase. It usually enhances strength
while reducing elongation. With the increase in Cu content, the
Fig. 6. SEM images of tensile fracture surfaces of Ti–10Mo-xCu alloy with different Cu contents: (a) Ti–10Mo; (b) Ti–10Mo–1Cu; (c) Ti–10Mo–3Cu; (d)
Ti–10Mo–5Cu.
Fig. 7. Merged images of live and dead cells on Ti–10Mo-xCu alloy of different Cu contents after culturing for different days.
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Ti–10Mo-xCu alloy presents higher Ti2Cu content (Fig. 3). As a result,
the strength of the Ti–10Mo-xCu alloy increases while the elongation
decreases gradually. Successful clinical application of the metal alloy
depends largely on meeting the requirements of mechanical properties,
namely a high strength and an elongation not less than 5%. Hence, the
Ti–10Mo–3Cu alloy with an optimal property with high strength of
1098.1 MPa and an acceptable elongation of 5.2% is a promising ma-
terial for medical implant. Compared with the Cu-bearing Ti alloys in
the literature, such as Ti–6Al–4V-xCu and Ti-xCu alloys, Ti–10Mo–3Cu
alloy exhibits higher tensile strength with an elongation lower than Ti-
xCu alloy (14.5%–26%) but higher values than Ti–6Al–4V-xCu
(0.2%–2.8%).
The microscopic fracture morphologies of Ti–10Mo-xCu alloy with
different Cu contents are shown in Fig. 6. Fewer pores are observed for
all alloys, owing to its near full density (relative density is above 98%,
Fig. 2). In addition, the fracture surfaces of all alloy display mixture of
dimples of varying size and coarse cleavage facet, which demonstrates
that the fracture mode of the Ti–10Mo-xCu alloy is a quasi-cleavage
fracture. But the size of the dimples become larger while the number
decreases, while the amount of cleavage surface increases with the rise
in Cu content. This result indicates that the strength of the alloys in-
creases and the elongation decreases with Cu content, which is in good
agreement with the tensile stress-strain curves.
3.3. Cytocompatibility
In order to investigate the potential application of Ti–10Mo-xCu
alloy for bone implants, MC3T3-E1 cells were used to evaluate the
cytocompatibility. In this study, the viability of the MC3T3-E1 cells
cultured on the surface of alloys after 1 and 3 days is evaluated using a
LIVE/DEAD kit. The merged live and dead images are shown in Fig. 7. It
can be seen that there are a few dead cells (fluorescent red) observed
and most of the cells are viable (bright fluorescent green) for all of the
alloys at day 1. With the prolongation of culture time to 3 days, there
are more viable cells on the surface of the alloys. In addition, there is no
significant difference in viable cells observed among the Ti–10Mo-xCu
alloy and control group, which indicates that the cells could proliferate
on all the newly developed Ti–10Mo-xCu alloy.
In order to qualify the proliferation of MC3T3-E1 cells on Ti–10Mo-
xCu alloy, CCK8 assay tests were carried out, and the cell CRGR is
calculated based on formula (1), and the results are shown in Fig. 8. It
can be seen that with the increasing culture time, cell proliferation
increases on all specimens. The CRGR of all alloys is higher than 100%
after 1 and 3 days. Based on ISO 10993–5 [34], the cytotoxicity level
for all Ti–10Mo-xCu alloy is categorized level 0. This result together
with the live and dead staining results indicates that none of the
Ti–10Mo-xCu alloys are cytotoxic to MC3T3-E1 cells.
3.4. Bacterial inhibitory property
Fig. 9 shows the CFU of E. coli and S. aureus bacteria cultured on the
surface of Ti–10Mo-xCu alloy and Ti–10Mo alloy (as control) after 24 h.
The CFU results suggest that there are large amounts of E. coli and S.
aureus grew on the surface of Ti–10Mo alloy compared with the
Ti–10Mo-xCu alloy after 24 h incubation. The CFU numbers of S. aureus
and E. coli colonies from Ti–10Mo-xCu alloy groups decrease with the
increase in Cu content. The calculated bacterial rate is shown in
Table 3. It can be seen that the bacterial inhibitory rates of Ti–10Mo-
xCu alloy increase with the Cu content after 24 h incubation. The
bacterial inhibitory rates of Ti–10Mo-xCu alloy against S. aureus are
about 20%, 40%, and 60%, respectively, while that against E. coli is
about 15%, 35%, and 50%.
The Cu ion release in the deionized water with the immersion time
is shown in Fig. 10. It can be seen that a relatively high Cu ion con-
centration is released from all Ti–10Mo-xCu alloy. In general, the
amount of Cu ion release increases linearly with the Cu content at the
same timepoint. The release amount at the first day for Ti–10Mo-xCu
alloy was in the range of 0.06–0.09 mg/L, which increases continually
with prolonged immersion time. After 7 days, the amount of released
Fig. 8. Viability of MC3T3-E1 cells cultured on Ti–10Mo-xCu alloy of different
Cu contents.
Fig. 9. Staphylococcus aureus and Escherichia coli bacterial colonies after incubation for 24 h on Ti–10Mo-xCu alloy with different Cu contents.
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Cu ion for Ti–10Mo–1Cu, Ti–10Mo–3Cu, and Ti–10Mo–5Cu alloy are
0.15 mg/L, 0.17 mg/L, and 0.20 mg/L, respectively.
The enhanced bacterial inhibitory properties of Ti–10Mo-xCu alloy
can be ascribed to the following factors: (1) the release of Cu ion; and
(2) the existence of the Ti2Cu phase. It has been suggested that Cu is a
broad bacterial inhibitory agent, mainly as a result of releasing Cu ion.
As shown in Fig. 8, the amount of releasing Cu2+ increases gradually
with the Cu content and time, meaning that it can sustainably kill
bacteria. In addition to the Cu2+, Ti2Cu also plays an important role in
killing bacteria. Base on previous studies [40], fine and dispersed Ti2Cu
phase could lead to a higher bacterial inhibitory rate. In this study, with
the Cu content increases, the release of Cu ion and the amount of the
Ti2Cu phase increase simultaneously, which leads to a gradual increase
in the bacterial inhibitory rate. However, compared with other Ti alloys
with the same Cu content [37–42], e.g. Ti-xCu and Ti–6Al–4V-xCu al-
loys, the bacterial inhibitory rate of Ti–10Mo-xCu alloy is still relatively
low. This might be caused by a different bacterial inhibitory me-
chanism, and the detailed bacterial inhibitory mechanism needs to be
explored in the future. Based on the above results, the Ti–10Mo–3Cu
alloy exhibits higher strength, excellent cytocompatibility, and com-
parable elongation and bacterial inhibitory properties, and it could be
considered as a promising candidate for bone-tissue engineering ap-
plication.
4. Conclusions
New Ti–10Mo-xCu alloy with the bacterial inhibitory effect is de-
veloped and fabricated from a PM route in this study. The micro-
structure, mechanical properties, cytocompatibility, and bacterial in-
hibitory property of the Ti–10Mo-xCu alloy are fully characterized. The
main conclusions are summarized as follows:
(1) Ti–10Mo-xCu alloy with a high relative density (about 98%) is
successfully fabricated by simple PM. All Ti–10Mo-xCu alloy shows
a typical Widmanstäten microstructure. Ti–10Mo–3Cu and
Ti–10Mo–5Cu alloys also have a small amount of Ti2Cu phases.
(2) A wide range of mechanical properties of Ti–10Mo-xCu alloy can be
achieved. The Ti–10Mo–3Cu alloy exhibits an optimal tensile
strength of 1098.1 MPa and elongation of 5.2%.
(3) No adverse effects of the Ti–10Mo-xCu alloy generated on the
MC3T3-E1 cell proliferation, and the cytotoxicity level is extremely
low (grade 0). With the increase in Cu content, the bacterial in-
hibitory rates of Ti–10Mo-xCu alloy increase gradually, and the
rates against S. aureus and E. coli are in the range of 20–60% and
15–50% after 24 h incubation, respectively.
(4) Ti–10Mo–3Cu alloy exhibits high strength, excellent cytocompat-
ibility, good elongation and bacterial inhibitory property, and
therefore can be considered for further study as a medical implant
material.
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Table 3
Bacterial inhibitory rate of Ti–10Mo-xCu alloy with different Cu contents.
Alloy Staphylococcus aureus number
(CFU × 107)




Escherichia coli bacterial inhibition rate
(%)
Ti–10Mo 4.11 – 6.17 –
Ti–10Mo–1Cu 3.19 22.4 5.16 16.4
Ti–10Mo–3Cu 2.39 41.8 3.93 36.3
Ti–10Mo–5Cu 1.59 61.3 3.01 49.9
Fig. 10. The cumulative Cu ion concentration in the deionized water with the
immersion time.
W. Xu, et al. Bioactive Materials 5 (2020) 659–666
665
References
[1] A. Nouri, C. Wen, 1-Introduction to Surface Coating and Modification for Metallic
Biomaterials, Surface Coating and Modification of Metallic Biomaterials, Woodhead
Publishing, 2015, pp. 3–60.
[2] M. Geetha, A.K. Singh, R. Asokamani, A.K. Gogia, Ti based biomaterials, the ulti-
mate choice for orthopaedic implants-A review, Prog. Mater. Sci. 54 (2009)
397–425.
[3] W. Xu, J.J. Tian, Z. Liu, X. Lu, M.D. Hayat, C. Huang, X.H. Qu, C.E. Wen, Novel
porous Ti35Zr28Nb scaffolds fabricated by powder metallurgy with excellent os-
teointegration ability for bone-tissue engineering applications, Mater. Sci. Eng. C
105 (2019) 110015.
[4] H. Kröger, P. Venesmaa, J. Jurvelin, H. Miettinen, O. Suomalainen, E. Alhava, Bone
density at the proximal femur after total hip arthroplasty, Clin. Orthop. Relat. Res.
352 (1998) 66–74.
[5] B. Aksakal, O.S. Yildirim, H. Gul, Metallurgical failure analysis of various implant
materials used in orthopedic applications, J. Fail. Anal. Prev. 4 (2004) 17–23.
[6] W. Xu, X. Lu, J.J. Tian, C. Huang, M.o Chen, Y. Yan, L.N. Wang, X.H. Qu, C.E. Wen,
Microstructure, wear resistance, and corrosion performance of Ti35Zr28Nb alloy
fabricated by powder metallurgy for orthopedic applications, J. Mater. Sci. Technol.
41 (2020) 191–198.
[7] W. Xu, X. Lu, M.D. Hayat, J.J. Tian, C. Huang, M. Chen, X.H. Qu, C.E. Wen,
Fabrication and properties of newly developed Ti35Zr28Nb scaffolds fabricated by
powder metallurgy for bone-tissue engineering, J. Mater. Res. Technol. 8 (2019)
3696–3704.
[8] W. Xu, X. Lu, L.N. Wang, Z.M. Shi, S.M. Lv, Q. Ma, X.H. Qu, Mechanical properties,
in vitro corrosion resistance and biocompatibility of metal injection molded Ti-
12Mo alloy for dental applications, J. Mech. Behav. Biomed. 88 (2018) 534–547.
[9] W. Xu, M. Chen, X. Lu, D.W. Zhang, H.P. Singh, J.S. Yu, Y. Pan, X.H. Qu, C.Z. Liu,
Effect of Mo content on corrosion and tribocorrosion behaviours of Ti-Mo ortho-
paedic alloys fabricated by powder metallurgy, Corrosion Sci. (2020) 108557.
[10] W.F. Ho, C.P. Ju, J.C. Lin, Structure and properties of cast binary Ti-Mo alloys,
Biomaterials 20 (1999) 2115–2122.
[11] W. Xu, Z. Liu, X. Lu, J.J. Tian, G. Chen, B.W. Liu, Z. Li, X.H. Qu, C.E. Wen, Porous
Ti-10Mo alloy fabricated by powder metallurgy for promoting bone regeneration,
Sci. China Mater. 62 (2019) 1053–1064.
[12] N.T.C. Oliveira, A.C. Guastaldi, Electrochemical stability and corrosion resistance of
Ti-Mo alloys for biomedical applications, Acta Biomater. 5 (2009) 399–405.
[13] W. Xu, X. Lu, B. Zhang, C.C. Liu, S.M. Lv, S.D. Yang, X.H. Qu, Effects of porosity on
mechanical properties and corrosion resistance of PM-fabricated porous Ti-10Mo
alloy, Metals 8 (2018) 188–201.
[14] V.R. Jablokov, M.J. Nutt, M.E. Richelsoph, H.L. Freese, The application of Ti-15Mo
beta titanium alloy in high strength structural orthopaedic applications, J. ASTM
Int. (JAI) 2 (2005) 1–8.
[15] J. Disegi, Wrought Titanium-15% Molybdenum Implant Material, SYNTHES®
Instruments and Implants, second ed., (April 2009).
[16] P.J. Bania, Beta titanium alloys and their role in the titanium industry, J. Occup.
Med. 46 (1994) 16–19.
[17] G. De Bastiani, R. Aldegheri, L. Renzi Brivio, The treatment of fractures with a
dynamic axial fixator, J. Bone Joint Surg. 66 (1984) 538–545.
[18] M. Deysine, Infections associated with surgical implants, N. Engl. J. Med. 351
(2004) 193–195.
[19] Y.Z. Wan, G.Y. Xiong, H. Liang, S. Raman, F. He, Y. Huang, Modification of medical
metals by ion implantation of copper, Appl. Surf. Sci. 253 (2007) 9426–9429.
[20] M. Yoshinari, Y. Oda, T. Kato, K. Okuda, Influence of surface modifications to ti-
tanium on bacterial inhibitory activity in vitro, Biomaterials 22 (2001) 2043–2048.
[21] X. Wang, H. Dong, J. Liu, G. Qin, D. Chen, E. Zhang, In vivo bacterial inhibitory
property of Ti-Cu sintered alloy implant, Mater. Sci. Eng. C 100 (2019) 38–47.
[22] B. Szaraniec, T. Goryczka, Structure, and properties of Ti-Ag alloys produced by
powder metallurgy, J. Alloys Compd. 709 (2017) 464–472.
[23] L. Zhang, J. Guo, T. Yan, Y. Han, Fibroblast responses and bacterial inhibitory ac-
tivity of Cu and Zn co-doped TiO2 for percutaneous implants, Appl. Surf. Sci. 434
(2018) 633–642.
[24] F. Heidenau, W. Mittelmeier, R. Detsch, M. Haenle, F. Stenzel, G. Ziegler,
H. Gollwitzer, A novel bacterial inhibitory titania coating: metal ion toxicity and in
vitro surface colonization, J. Mater. Sci. 16 (2005) 883–888.
[25] L. Ren, H.M. Wong, C.H. Yan, Kelvin W.K. Yeung, K. Yang, Osteogenic ability of
Cu‐bearing stainless steel, J. Biomed. Mater. Res. Part B 103B (2015) 1433–1444.
[26] K. Glenske, P. Donkiewicz, A. Köwitsch, N. Milosevic-Oljaca, P. Rider, S. Rofall,
J. Franke, O. Jung, R. Smeets, R. Schnettler, S. Wenisch, M. Barbeck, Applications of
metals for bone regeneration, Int. J. Mol. Sci. 19 (2018) 826–858.
[27] H. Chai, L. Guo, X. Wang, Y. Fu, J. Guan, L. Tan, L. Ren, K. Yang, Bacterial in-
hibitory effect of 317L stainless steel contained copper in the prevention of implant-
related infection in vitro and in vivo, J. Mater. Sci. Mater. Med. 22 (2011)
2525–2535.
[28] T. Shirai, H. Tsuchiya, T. Shimizu, K. Ohtani, Y. Zen, K. Tomita, Prevention of pin
tract infection with titanium-copper alloys, J. Biomed. Mater. Res. B 91B (2009)
373–380.
[29] E.R. Zhang, F. Li, H.Y. Wang, J. Liu, C.M. Wang, M.Q. Li, K. Yang, A new bacterial
inhibitory titanium-copper sintered alloy: preparation and bacterial inhibitory
property, Mater. Sci. Eng. C 33 (2013) 4280–4287.
[30] L. Ren, Z. Ma, M. Li, Y. Zhang, W.Q. Liu, Z.H. Liao, K. Yang, Bacterial inhibitory
properties of Ti-6Al-4V-xCu alloys, J. Mater. Sci. Technol. 30 (2014) 699–705.
[31] W. Xu, M. Li, C.E. Wen, S.M. Lv, C.C. Liu, X. Lu, X.H. Qu, The mechanical properties
and in vitro biocompatibility of pm-fabricated Ti-28Nb-35.Zr alloy for orthopedic
implant applications, Materials 11 (2018) 531–543.
[32] W. Xu, S.Q. Xiao, X. Lu, G. Chen, C.C. Liu, X.H. Qu, Fabrication of commercial pure
Ti by selective laser melting using hydride-dehydride titanium powders treated by
ball milling, J. Mater. Sci. Technol. 35 (2019) 322–327.
[33] ASTM B962-14, Standard Test Methods for Density of Compacted or Sintered
Powder Metallurgy (PM) Products Using Archimedes' Principle, ASTM
International, West Conshohocken, PA, 2017.
[34] ISO 10993-5, Biological Evaluation of Medical Devices-Part 5: Tests for
Cytotoxicity: in Vitro Methods, ANSI/AAMI, Arlington, VA, 1999.
[35] QB/T 2591, Antimicrobial Plastics Test for Antimicrobial Activity and Efficacy,
(2003).
[36] K.N. Campo, E.S.N. Lopes, C.J. Parrish, R. Caram, Rapid quenching of semisolid Ti-
Cu alloys: insights into globular microstructure formation and coarsening, Acta
Mater. 139 (2017) 86–95.
[37] Z. Ma, M. Li, R. Liu, L. Ren, Y. Zhang, H.B. Pan, Y. Zhao, K. Yang, In vitro study on
an bacterial inhibitory Ti–5Cu alloy for medical application, J. Mater. Sci. Mater.
Med. 27 (2016) 91–103.
[38] T. Aoki, I.C.I. Okafor, I. Watanabe, M. Hattori, Y. Oda, T. Okabe, Mechanical
properties of cast Ti‐6Al‐4V‐XCu alloys, J. Oral Rehabil. 31 (2011) 1109–1114.
[39] J.W. Wang, S.y. Zhang, Z.Q. Sun, H. Wang, L. Ren, K. Yang, Optimization of me-
chanical property, bacterial inhibitory property and corrosion resistance of Ti-Cu
alloy for dental implant, J. Mater. Sci. Technol. 35 (2019) 2336–2344.
[40] E.L. Zhang, J. Ren, S.Y. Li, L. Yang, G.W. Qin, Optimization of mechanical prop-
erties, biocorrosion properties and antibacterial properties of as-cast Ti-Cu alloys,
Biomed. Mater. 11 (2016) 065001.
[41] Z. Ma, M. Yao, R. Liu, K. Yang, L. Ren, Y. Zhang, Z. Liao, W. Liu, M. Qi, Study on
bacterial inhibitory activity and cytocompatibility of Ti-6Al-4V-5Cu alloy, Mater.
Technol. 30 (sup6) (2015) B80–B85.
[42] J. Liu, X.X. Zhang, H.Y. Wang, F.B. Li, M.Q. Li, K. Yang, E.L. Zhang, The bacterial
inhibitory properties and biocompatibility of a Ti-Cu sintered alloy for biomedical
application, Biomed. Mater. 9 (2014) 025013.
W. Xu, et al. Bioactive Materials 5 (2020) 659–666
666
